Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivatives.

Parkkari T, Savinainen JR, Rauhala AL, Tolonen TL, Nevalainen T, Laitinen JT, Gynther J, Järvinen T.

Bioorg Med Chem Lett. 2004 Jun 21;14(12):3231-4.

PMID:
15149681
2.

Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE).

Parkkari T, Salo OM, Huttunen KM, Savinainen JR, Laitinen JT, Poso A, Nevalainen T, Järvinen T.

Bioorg Med Chem. 2006 Apr 15;14(8):2850-8. Epub 2006 Jan 5.

PMID:
16403642
3.

Alpha-methylated derivatives of 2-arachidonoyl glycerol: synthesis, CB1 receptor activity, and enzymatic stability.

Parkkari T, Myllymäki M, Savinainen JR, Saario SM, Castillo-Meléndez JA, Laitinen JT, Nevalainen T, Koskinen AM, Järvinen T.

Bioorg Med Chem Lett. 2006 May 1;16(9):2437-40. Epub 2006 Feb 8.

PMID:
16466915
4.

Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas.

Ng EW, Aung MM, Abood ME, Martin BR, Razdan RK.

J Med Chem. 1999 Jun 3;42(11):1975-81.

PMID:
10354405
5.

Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats.

Cippitelli A, Bilbao A, Hansson AC, del Arco I, Sommer W, Heilig M, Massi M, Bermúdez-Silva FJ, Navarro M, Ciccocioppo R, de Fonseca FR; European TARGALC Consortium.

Eur J Neurosci. 2005 Apr;21(8):2243-51.

PMID:
15869521
6.
7.

High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor.

Li C, Xu W, Vadivel SK, Fan P, Makriyannis A.

J Med Chem. 2005 Oct 6;48(20):6423-9.

PMID:
16190768
8.

Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.

Haller VL, Cichewicz DL, Welch SP.

Eur J Pharmacol. 2006 Sep 28;546(1-3):60-8. Epub 2006 Jul 25.

PMID:
16919265
9.

Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.

Song KS, Lee SH, Chun HJ, Kim JY, Jung ME, Ahn K, Kim SU, Kim J, Lee J.

Bioorg Med Chem. 2008 Apr 1;16(7):4035-51. doi: 10.1016/j.bmc.2008.01.023. Epub 2008 Jan 19.

PMID:
18243711
10.

Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.

Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M.

Eur J Pharmacol. 2007 Nov 14;573(1-3):11-9. Epub 2007 Jul 4.

PMID:
17644084
11.

Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.

Bermúdez-Siva FJ, Serrano A, Diaz-Molina FJ, Sánchez Vera I, Juan-Pico P, Nadal A, Fuentes E, Rodríguez de Fonseca F.

Eur J Pharmacol. 2006 Feb 15;531(1-3):282-4. Epub 2006 Jan 19.

PMID:
16423347
12.
13.

Synthesis and activity of 1,3,5-triphenylimidazolidine-2,4-diones and 1,3,5-triphenyl-2-thioxoimidazolidin-4-ones: characterization of new CB1 cannabinoid receptor inverse agonists/antagonists.

Muccioli GG, Wouters J, Charlier C, Scriba GK, Pizza T, Di Pace P, De Martino P, Poppitz W, Poupaert JH, Lambert DM.

J Med Chem. 2006 Feb 9;49(3):872-82.

PMID:
16451053
14.

Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimetics.

Di Marzo M, Casapullo A, Bifulco G, Cimino P, Ligresti A, Di Marzo V, Riccio R, Gomez-Paloma L.

J Pept Sci. 2006 Sep;12(9):575-91.

PMID:
16534762
15.

Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.

Diaz P, Xu J, Astruc-Diaz F, Pan HM, Brown DL, Naguib M.

J Med Chem. 2008 Aug 28;51(16):4932-47. doi: 10.1021/jm8002203. Epub 2008 Jul 31.

PMID:
18666769
16.

Peripheral cannabinoid CB1 receptors inhibit evoked responses of nociceptive neurones in vivo.

Kelly S, Donaldson LF.

Eur J Pharmacol. 2008 May 31;586(1-3):160-3. doi: 10.1016/j.ejphar.2008.03.003. Epub 2008 Mar 13.

PMID:
18410918
17.

Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptors.

Govaerts SJ, Muccioli GG, Hermans E, Lambert DM.

Eur J Pharmacol. 2004 Jul 8;495(1):43-53.

PMID:
15219819
18.

Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory.

Clarke JR, Rossato JI, Monteiro S, Bevilaqua LR, Izquierdo I, Cammarota M.

Neurobiol Learn Mem. 2008 Sep;90(2):374-81. doi: 10.1016/j.nlm.2008.04.009. Epub 2008 Jun 3.

PMID:
18524639
19.

Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.

Sagar DR, Kelly S, Millns PJ, O'Shaughnessey CT, Kendall DA, Chapman V.

Eur J Neurosci. 2005 Jul;22(2):371-9.

PMID:
16045490
20.

The anandamide transport inhibitor AM404 reduces ethanol self-administration.

Cippitelli A, Bilbao A, Gorriti MA, Navarro M, Massi M, Piomelli D, Ciccocioppo R, Rodríguez de Fonseca F.

Eur J Neurosci. 2007 Jul;26(2):476-86.

PMID:
17650118
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk